Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Trying to figure out what to do with Roblox stock right now? You are not alone. After a massive 117.9% run so far this year and a jaw-dropping 214.4% surge over the past twelve months, Roblox has ...